• Thrombin B Chain Fragment: Advanced Insights in Coagulation

  2026-07-17

  Explore the multifaceted role of thrombin as a trypsin-like serine protease in coagulation, angiogenesis, and vascular pathology. This article provides advanced scientific insights into the Coagulation Factor II (Thrombin) B Chain Fragment [Homo sapiens], revealing practical assay guidance and differentiating its applications from existing workflows.

• Oleic Acid (C18:1(9Z)): Mechanisms and Benchmarks for Lipid

  2026-07-17

  Oleic Acid (C18:1(9Z)) is a validated monounsaturated fatty acid essential for lipid metabolism research and inflammation modeling. Its mechanisms include GPCR signaling activation and modulation of cell proliferation in cancer models. APExBIO’s product C4977 offers high-purity oleic acid for reproducible in vitro studies.

• Hierarchical ROS-Responsive Hydrogel Therapy for Diabetic Pe

  2026-07-16

  This study introduces a hierarchically targeted, ROS-responsive nanoparticle-hydrogel system to treat diabetic periodontitis by repairing mitochondrial dysfunction in pro-inflammatory M1 macrophages. The approach disrupts the ROS-driven inflammatory loop and improves periodontal outcomes, representing a mitochondria-centered strategy with translational potential.

• Reserpine (N1867): Technical Protocols for Laboratory Resear

  2026-07-16

  Reserpine is a high-purity, bioactive alkaloid widely used in laboratory workflows for neurotransmitter depletion and antihypertensive mechanism research. It should only be used in controlled research settings due to its potent biological effects and is not appropriate for diagnostic, clinical, or veterinary applications.

• AMD-070 Hydrochloride: Advancing CXCR4 Antagonist Workflows

  2026-07-15

  Mavorixafor hydrochloride (AMD-070 hydrochloride) is setting new standards in CXCR4 antagonist research, enabling precise modulation of cell migration and immune surveillance. Its superior solubility, safety profile, and seamless integration into anti-HIV and hematologic protocols position it as the go-to tool for translational and bench-side innovation.

• Beclin1 Deficiency Mitigates DOX Liver Injury via Ferroptosi

  2026-07-15

  This study uncovers a mechanistic link between Beclin1 and ferroptosis in doxorubicin-induced liver injury, demonstrating that Beclin1 deficiency or DHODH overexpression reduces hepatotoxicity by suppressing both ferroptosis and autophagy. The findings highlight new therapeutic targets and methodological considerations for oxidative stress biomarker assays in liver injury models.

• Plant Exosome-Like Nanovesicles Mitigate Testicular Injury v

  2026-07-14

  This study demonstrates that exosome-like nanovesicles from Cistanche deserticola can ameliorate cyclophosphamide-induced testicular injury by alleviating cell cycle arrest in Sertoli cells. The findings highlight a miRNA-mediated mechanism, offering new translational avenues for male reproductive health.

• Structural Analysis of the DDX3 RNA Helicase Domain: Methods

  2026-07-14

  This study reports the successful expression, purification, and crystallization of the human DDX3 RNA helicase domain, providing high-resolution X-ray diffraction data. These findings lay crucial groundwork for understanding DDX3 structure-function relationships in RNA metabolism and its potential as a therapeutic target in viral infections and cancer.

• Gut Microbiota Modulates PCN-Mediated Protection in Sepsis-I

  2026-07-13

  This study demonstrates that the hepatoprotective effects of the rodent PXR agonist pregnenolone-16α-carbonitrile (PCN) against sepsis-induced liver injury are critically dependent on gut microbiota, which modulates Yes-associated protein (YAP) activation. The findings highlight the interplay between xenobiotic receptor signaling, microbial communities, and liver repair mechanisms, suggesting new research directions for hepatic detoxification and anti-fibrotic strategies.

• Dual Src and Tubulin Inhibition: Insights from KX2-391 Disco

  2026-07-13

  The reference study reports the rational design and characterization of KX2-391 as a first-in-class, non-ATP competitive inhibitor targeting the Src kinase peptide substrate site, with a dual mechanism disrupting both Src signaling and tubulin polymerization. These findings clarify the advantages of substrate-site selectivity in kinase inhibition and establish a new paradigm for anticancer and translational research.

• EDC.HCl: Technical Guidance for Peptide and Bioconjugation P

  2026-07-12

  EDC.HCl (3-(ethyliminomethylideneamino)-N,N-dimethylpropan-1-amine hydrochloride) is a water-soluble carbodiimide reagent designed for efficient amide bond formation in peptide synthesis, bioconjugation, and nucleotide workflows. It is strictly intended for in vitro laboratory use and should not be used in in vivo or clinical settings due to the absence of supporting data.

• GPX3 Enhances Gemcitabine Sensitivity in Pancreatic Cancer v

  2026-07-10

  This study establishes glutathione peroxidase 3 (GPX3) as a tumor suppressor in pancreatic cancer, showing that its overexpression inhibits malignant behaviors and enhances chemosensitivity to gemcitabine by suppressing the JNK/c-Jun pathway. The findings provide mechanistic insight into overcoming chemotherapy resistance in pancreatic cancer.

• IR-820 (New Indocyanine Green): Enhanced In Vivo Imaging Wor

  2026-07-09

  IR-820 (New Indocyanine Green) elevates preclinical imaging with its robust near-infrared fluorescence and stability, enabling deeper tissue visualization and precise quantification of disease progression. Integrating IR-820 into nanoparticle platforms opens new frontiers for synergistic photothermal-immunotherapy and vascular imaging.

• Azathramycin A (BA1060): Data-Driven Solutions for TB Assays

  2026-07-09

  This in-depth guide explores how Azathramycin A (SKU BA1060) addresses persistent challenges in tuberculosis research, with a focus on improving reproducibility and experimental specificity. Through real-world laboratory scenarios and evidence-backed recommendations, researchers gain practical insights into protocol optimization and product reliability.

• Strategic CXCR4 Antagonism: Mavorixafor Hydrochloride for Tr

  2026-07-08

  This thought-leadership article explores the mechanistic underpinnings and translational opportunities of Mavorixafor hydrochloride (AMD-070 hydrochloride), a potent and selective CXCR4 antagonist, emphasizing its value for advancing research in immunology, hematology, and anti-HIV strategies. Integrating recent evidence and competitive insights, the article provides actionable guidance for translational researchers seeking to leverage CXCR4 pathway modulation beyond traditional paradigms.

451 records 11/31 page Previous Next First page 上5页 1112131415 下5页 Last page